Actively Recruiting
Intelligent Management Platform for Guiding Exercise Rehabilitation in Coronary Heart Disease Patients
Led by China National Center for Cardiovascular Diseases · Updated on 2025-12-02
200
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
C
China National Center for Cardiovascular Diseases
Lead Sponsor
C
Chinese Academy of Medical Sciences
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to find out if an artificial intelligence (AI)-enabled stratified management platform can help adults with coronary heart disease (CHD) better perform exercise rehabilitation and manage their health after being discharged from the hospital. The main questions it aims to answer are: 1. Does using the AI platform lead to a greater improvement in exercise capacity (measured by peak oxygen consumption, VO2peak) after 3 months? 2. Does the platform help increase daily physical activity, improve exercise adherence and motivation, and better control modifiable cardiovascular risk factors? 3. Is guiding home-based exercise with this platform safe for low-risk CHD patients? Researchers will compare the AI Management Group (using the platform and a sports wristband) to the Routine Management Group (receiving usual care without the platform) to see if the AI group shows more significant improvements in fitness and health metrics. Participants will: 1. Be randomly assigned to either use the AI platform or receive usual post-discharge care. 2. Receive a personalized exercise prescription from a doctor before going home. 3. If in the AI group: Use the smartphone app and wearable device to track health data for comprehensive post-discharge management, and receive reminders and immediate safety alerts. 4. Attend a follow-up visit at 3 months for check-ups and tests, including an exercise test and health assessments. The study hopes to show that this intelligent management platform is an effective and safe tool to help people with CHD recover at home, stay active, and reduce future heart risks.
CONDITIONS
Official Title
Intelligent Management Platform for Guiding Exercise Rehabilitation in Coronary Heart Disease Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- CHD patients aged over 18 years
- Classified as low-risk for cardiovascular events during exercise and by GRACE risk score
- Ability of the patient or close relatives to use smartphones and applications
- Willingness to participate and sign the informed consent form
You will not qualify if you...
- Residual stenosis >50% in left main coronary artery or >70% stenosis in other major vessels
- Planned coronary revascularization within 3 months
- Acute myocardial infarction within past 1 month
- Severe cognitive impairment
- Severely impaired exercise capacity
- Advanced-stage malignancy
- Life expectancy less than 3 months
- Severe multi-organ failure
- Conditions unsuitable for home-based exercise rehab as assessed by specialist
- Refusal to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fuwai Hospital, Chinese Academy of Medical Sciences/National Center for Cardiovascular Diseases
Beijing, Beijing Municipality, China, 100037
Actively Recruiting
Research Team
P
Prof. Gao, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here